Quick Answer
CRESCENT BIOPHARMA, INC. reported Total Revenue of $10.84 million for fiscal year 2025.
CRESCENT BIOPHARMA, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $10.84M | +58516.2% |
| 2016 | $18.5K | -99.9% |
| 2015 | $20.07M | +33.6% |
| 2014 | $15.03M | +276.4% |
| 2013 | $3.99M | -73.8% |
| 2012 | $15.26M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2016 | $18.5K | — | -99.9% |
| June 30, 2015 | $20.00M | +33.1% | — |
| March 31, 2015 | $0.00 | — | -100.0% |
| June 30, 2014 | $15.03M | +27185.1% | +0.2% |
| May 31, 2014 | $15.00M | — | — |
| March 31, 2014 | $0.00 | -100.0% | -100.0% |
| September 30, 2013 | $52.6K | — | -4.5% |
| June 30, 2013 | $55.1K | — | -98.6% |
- CRESCENT BIOPHARMA, INC. showed an increase of +58516.2% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2025 period, CRESCENT BIOPHARMA, INC.’s total revenue has declined by 28.9% (from $15.26 million to $10.84 million).
- The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: